Maria Lazaro is a Pharmacist from Complutense University of Madrid. He/She(according to the author’s gender) holds advanced master’s in Biotechnology and Pharmaceutical Management works for Seppic in Human Biologicals department (adjuvants for vaccines and excipients for injectables ) since 2012.
animal health, vaccine manufacture, vaccine development
animal health, vaccine manufacture, vaccine development
Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Researcher in the University of São Paulo, in the Ophthalmology department from 2012 to 2013.
animal health, vaccine manufacture, vaccine development
Vidmi Taolam Martin is pursuing his PhD in Orthopedic and Trauma Surgery at Southern Medical University, Zhujiang Hospital (Guangzhou, China). He is the author of a book and has published several papers in scientific journals.
Orthopedic and Trauma Surgery
Professor Seki has been graduated from Department of Medicine, Nagasaki University, as Medical Doctor, with the specialties including Internal Medicine, Infectious Diseases, and Infection Control. Later on he obtained his post-graduation, started working at Osaka University. Presently he has been working at the Tohoku Medical and Pharmaceutical University, Sendai City, Japan.
Internal Medicine, Infectious Diseases, and Infection Control
Short Biography Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals/other international journals. He is Advisory Board Member for Photon Journal. He is a Fellow of the International Agency for Standards and Ratings (IASR). He conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. He is Chief Editor for International Journal of Diabetes Research (2014-2019), Research and Reviews: Neuroscience (2016-2019) and Journal of Diabetes and Clinical Studies (2017-2019). He is BIT Member (BIT Congress. Inc) with an H-index of 65 and Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu with citations >4800. Researchgate Analysis: RG score (>96%) of international Scientists. He acquired 71 International Certificates. He is a reviewer for approx. 47 journals over the past five years. Now he is in the 98th percentile as assessed for Publons users by merit. He is Advisory Committee and Organizing Board Member for various international conferences (2018-2019).
Interested in Chronic Diseases
Pierre A. MORGON is CEO of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement. He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, and of Vaccitech. Pierre has over 30 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies. He is a lecturer in several MBA programs in world-class business schools and in life science conferences, and at the Mass Challenge biotechnology incubator in Switzerland. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD and IMD.
Besides active involvement in teaching modern biochemistry/biotechnology courses to M.Sc./Ph.D students, Prof. Owais has successfully established a small but active research group with focus on nano-particle-based novel delivery systems including dendrimers/virosomes for gene packaging and liposomes, niosomes, microspheres, solid core lipid nano-particles for vaccine delivery, gene delivery, targeted drug delivery etc; with a view to increase the efficacy and safety of encapsulated chemo-therapeutic agents/sub-unit vaccines against some important infectious diseases. The research focus of Prof. Owais group has been on: Nanoparticles based antigen/DNA vaccines against various infectious diseases with special converge on intracellular pathogens. Novel nano-carriers for targeted delivery of encapsulated therapeutic agents (siRNA/chemical compounds) for improved treatment of cancer and some imperative infectious diseases. Nanoparticles with assorted applications in the field of diagnostics, taste/odor masking and treatment of hyperbilirubinemia in model animals. A glance at some of the coveted academic achievements: National Bioscience Award-2007 by DBT, Govt. of India Rashtriya Gaurav Award-2013 Trav. Bursary Award (JAPAN)-2014 TATA Innovation Award-2013 Young Scientist Award (MYSA) -2002 Best University Teacher Award-2009 Outstanding University Researcher Award-2008 Fogarty International Fellow, NIH, (USA) Published work displayed on cover page of FEMS Immunol. Med Microbiology for all the issues of Year 2006 Published work highlighted on cover page of Molecular Medicine in May-June issue of Year 2007 Technology Transfer to Cadilla Pharmaceuticals Ltd. under PRDSF program of DST, Govt. of India Technology Transfer to Gennova Pharmaceuticals Ltd. GATE 1987, Percentile 98.89; GATE 1988, percentile 97.36 UGC-CSIR Research Fellow (JRF 1988 & JRF 1989) The article entitled as Phospholipid diversity: correlation with membrane membrane fusion events. Biochim Biophys. Acta (Biomembrane) (2005) 1669: 170-181 was categorized among top 25 by Science Direct. Another article entitled as Ethanol production from crude whey by Kluyveromyces marxianus. Biochemical Engineering Journal (2006) 27: 295-297 was categorized among top 25 by Science Direct. Best poster Award on work entitled as Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multidrug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice at Indo-Australian Conference on Biotechnology in infectious diseases at Kasturba Medical College, MAHE, Manipal. Best poster Award on work entitled as Fusogenic potential of sperm membrane lipids: Natures wisdom to accomplish targeted gene delivery at International symposium on the Predictive, Preventive and Mechanistic Mutagenesis & XXXIII EMSI annual Meeting, AMU, Aligarh during Jan 1-3, 2008. Three articles co-authored by applicant have been ranked with THREE STARS by BIOWIZARD, The Biomedical Research Portal. 1. Sharma et. al. (2006) Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice, Vaccine 24(7): 948-956. 2. Bajpai et. al. (2005) Concomitant delivery of tetracycline and DEC against experimental filariasis. J Drug Targetting 13(6): 375-381. 3. Mittal et. al. (2005) Expression, purification and characterization of Leishmania donovani trypanothione reductase in E. coli. Protein Expression and Purification 40: 279-286.
Nanoparticles based antigen/DNA vaccines against various infectious diseases with special converge on intracellular pathogens.
Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine <firstname.lastname@example.org , The Journal of Rheumatology, Allergologia et Immunopathologia and others. She is a member of number International Project, like of “the European Forum on Antiphospholipid Antibodies”, “Multicenter studies antiphospholipid antibodies, infections and autoimmune diseases”. She is a mentor/ Supervisor ships a numbers of post-doc students. She was in Invited Speaker for many lectures in Congresses and Symposia; organizer and Chairman of many Workshops, Seminars and Symposia; member of the Steering Committee of the “(EULAR) recommendations for vaccination in patients with auto-immune inflammatory rheumatic diseases (AIIRD)”, and EULAR Honorary Member; chairman in the International Congress “Antiphospholipid syndrome (Hughes syndrome) importance of multidisciplinary approaches- 30 years since definition”, 2013, “GRANT 2015” of the EUROPEAN STROKE CONFERENCE » for “excellent research in cerebrovascular diseases reviewed by the Scientific and programmer Committees”, and presented at the 24th Annual Meeting; Vienna, may, 2015. Member of ILLUMINATE steering committee: the phase 3 lupus ILLUMINATES clinical trials of Tabalumab/ Eli Lilly and Company., MD, PhD, FRCP, are willing to serve as a consultant to Lilly Research Laboratories, a division of Eli Lilly and Company (“Lilly”), in connection with the development of Tabalumab also known as LY2439821. Co- Chairman and the lector “LUPUS ACADEMY EASTERN EUROPEAN ROADSHOW of EULAR«: Belgrade, 18TH MARCH 2016, www.lupus-academy.org. Member of the American Association for the Advancement of Science (AAAS) from 2017. Professor Ljudmila Stojanovich’ Impact Point is 300.14, and number of citattions is 1,444.
ANTIPHOSPHOLIPID ANTIBODIES: CLINICAL AND DIAGNOSTIC PROBLEM AS AN INTRIGUING NOTIONS ON IMMUNOLOGY
Got the Young Scientist Award, Aufau International Award 2016, Organised by Chemical Sciences review and Letters Life time Member of “The Association of Pharmaceutical Teachers of India”. UK/LM-110. International Editorial Advisory Board member (Chemistry and Analytical Chemistry) at Cambridge Scholars Publishing Cambridge Scholars Publishing Lady Stephenson Library Welbeck Road Newcastle upon Tyne NE6 2PA United Kingdom
? Organic Chemistry: ? Analytical Chemistry: ? Physical Chemistry: ? In-organic Chemistry: ? Pharmaceutical chemistry: ? Phytochemistry: ? Natural product chemistry ? Biochemistry
Mario Rodriguez has his expertise in Virology and Bioprocess Development. Working with recombinants and their aplications against viral diseases as Influenza, Ebola and members of the Polyomaviride family like the newly discovered MCPyV. Scientist and Innovation manager with expertise in prototype technology projects that results in commercial technology (i.e. High fidelity DNA polymerase under commercialization, vaccines and Mononoclonal antibodies, licensed), advisor of technological companies in USA and Mexico. He is part in Mexico from SNI (National Researchers System) from CONACYT.
Rational synthetic biology approach to develop faster and accurate vaccines designed against Influenza
Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France). He was certified, by the United Nations for Basic Notion of Security on the Ground-Protection, Health and behavior, by the International Agency for Research on Cancer (IARC)/World Health Organization, Lyon (France) for Safety Certificate. He has published 1 Book with a style of philosophical story. Author of the world program against cancer in low and middle incomes countries, he is lead author (first listed) of more than 90 peer-reviewed research articles published in reputed journals. He is Review Board Member of Acta Scientific Medical Sciences (ASMS), Acta Scientific Microbiology (ASMI), Research and Reviews on Healthcare: Open Access Journal (RRHOAJ), and Editorial Board Member of the Journal of Medicine and Medical Sciences (JMMS), Modern Journal of Medicine and Biology (MJMB), EC Microbiology, International Journal of Clinical Virology (IJCV), Acta Scientific Cancer Biology (ASCB), BioMed Research Journal (BMRJ), Journal of Medicine and Biology (JMB), Biomedical Research, International journal of vaccines and technologies (IJVT), Journal of Surgery, Operative Techniques and Anaesthesia (JSOTA), Current Research in Bioengineering & Biomedical Sciences (CRBBS), Journal of Women's Health, Gynecology & Obstetrics (JWHGO), Trauma & Emergency Care journal, Journal of Current Medical Research and Opinion (JCMRO), International Journal of Clinical Pharmacology & Pharmacotherapy (IJCPP), Journal of Clinical Microbiology and Infectious Diseases (JCMID), Journal of Retro Virology and Anti Retro Virology (JRVAV), Journal of Antivirals and Antiretrovirals, Research and Reports in Immunology (RRI), Journal of Medical Case Reports and Reviews (JMCRR), Pyrex Journal of Biomedical Research (PJBR), Advances in Immunology and Microbiology (ADIM), Current Scientific Research in Biomedical Sciences (CSRBS), Journal of Clinical & Experimental Immunology (JCEI), Journal of AIDS and HIV Treatment, Edelweiss Journal of AIDS, Journal of HIV and AIDS, Journal of HIV and AIDS Research, Associate Editors for Journal of Bacteriology & Mycology
Human Papillomavirus Infection in genital Women in four regions of Senegal
Professor Dr. Sorush Niknamian holds Ph.D. in Cellular and Molecular Biology, B.Sc. in Mechatronics Engineering, B.Sc. in Applied Mathematics, He is a CSci (Chartered Scientist), RSciTech (Registered Science Technician), RSci (Registered Scientist) and Science Council, United Kingdom and Indiana Cancer Consortium (ICC) certified. He has been published 27 books in medical and biological sciences including Medicine, Nutrition, Cancer Prevention and Treatment. He has published 30 research articles in international high impact journals in many fields of medicine. He is the Board member of Weston A. Price Foundation in Washington, United States, Member of American Association for Cancer Research (AACR), Ambassador of European Association for Cancer Research (EACR), Member of Federal Health Professionals in the United States Marine Forces, Army Forces and Military Medicine.
The relation between the quantum entanglement in theoretical physics as a new insight into the cancer biology
Prof. Yongxiang Zhao is the innovative leading talent of National "Ten Thousand Talent Programme", the director of the National Center for International Research of Biological Targeting Diagnosis and Therapy, the moderator of the BIT’s 5th World Gene Convention Keynote Forum---Nobel Laureate Forum, the national talented person of “New Centuary National Hundred, Thousand and Ten Thousand Talent Project”. The leader of National Innovative Talent Promotion Program---Innovation Team of National Key Fields, the leader of National Innovation Team for the Changjiang Scholars Project, the expert of National "Ten Thousand Talent Programme" and “Changjiang Scholars Programme”, the expert of National Natural Science Foundation of subject review group, the standing director of Chinese Immunological Society, the member of Chinese Medical Association Professional Committee of Clinical Precision Medicine, the expert of National Science and Technology Award assessment, the member of Chinese medical science and Technology Award Evaluation Committee, the member of Gene Therapy Branch of Chinese Medical Association. The reviewers and editorial board members of multiple SCI journals such as Nature. He has taken charge of 14 national science and technology major projects and 16 provincial and ministerial projects.
Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of Applied Clinical Cognitive Neuropsychology from the USA. Prof. Dr. Aleezaadeh Completed his Ph.D. Degrees in Psychology at the USA. He completed his Master's Degree in Clinical Psychology at I. R. of the IRAN and Bachelor's Degree in General Psychology at I. R. of the IRAN. He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in the Green Lake (GreenLake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN.
Cognitive Sciences; Cognitive Neurosciences; Neuroimaging; Applied Clinical Cognitive Neuropsychology; Brain ( Cranial ) Imaging; Traditional Islamic-Iranian and, Chinese Medicines; Homeopathic Medicine and, Combination of Medical And, Psychological trends for eradicating illnesses / sicknesses.
Uqbah Iqbal is a Socioeconomic Researcher at Research for Social Advancement. Winning Second Place in Malaysian Historical Essay Writing Competition 2013, he was the recipient of Research University Fellowship Scheme, Graduate on Time Award and Outstanding Student Award from Faculty of Social Sciences and Humanities as well as the Youngest Ph.D. in History Holder and the only Malaysian achieved a Ph.D. in History in conjunction with the 43rd Convocation of Universiti Kebangsaan Malaysia. He's authoring notable books/ebooks such as The Historical Development of the Malay Nationalism Before Independence, The Historical Development of the Malay Society Economic Nature During Pre-Colonial Era, The Historical Development of British Investment in Malaya Before the Second World War, The Historical Development of Foreign Investment in the Formation of the Malaysian Economy and Sejarah Pemikiran Pandang Ke Timur: Kepentingan Jepun Dalam Pembangunan Sosio-Ekonomi Malaysia (1906-1980). His publications have appeared in a wide range of international and national journals such as TAWARIKH, SUSURGALUR, Management and Administrative Sciences Review, Social and Basic Sciences Research Review, Jurnal Kemanusiaan, Jurnal Sejarah, Jurnal Pengajian Melayu, Jebat, International Journal of Social Science and Humanities Research, Asia Pacific Journal of Education, Arts and Sciences, Asian Social Science and Geografia. He's also actively in the editorial board such as Asian Social Science, International Journal of Art and Literature, International Journal of Archaeology and History, American Journal of Social Sciences, Asia Pacific Journal of Education, Arts and Sciences, Social Sciences, Humanities and Social Sciences, History Research and Pratidhwani the Echo. Through his involvement as a reviewer with the Nonfiction Authors Association, 15 of his reviewed books received Awards.
Humanities and Social Sciences
Ajit Kumar Varma has obtained his B.Pharm from Gautam Buddh Technical University(GBTU), Lucknow, And M.Pharm (Pharmaceutics) from Rajiv Gandhi Proudyogiki Vishwavidyalaya (RGPV), Bhopal. He is currently working as an Assistant Professor at School of Pharmacy, Lingaya's University, Faridabad, India. He has above five years of Pharmaceutical Industry and academic in a good experience. He has been one research project publish in Lambert Publication,Germany. He has attended several National and International Conferences/Workshops-Seminars. He has credit in Nobel Researchers Awards as well as Young Scientist Awards and published several papers in International Journals, conferences and proceedings. He has been Editorial Reviewer member of several Journals as well as different Membership of Educational Society.
Novel Drug Delivery system, Research and Development, Formulation and Development, Pharmacovigilance, Clinical Research and Quality Management System